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Abstract
Background: The purpose of this study was to examine the relationship between the cancer health burden and
themagnitude of work disability on cancer survivors in Australia from 2003 to 2017.
Methods: A longitudinal prospective study design was undertaken among cancer patients using data from the
Household, Income and Labour Dynamics in Australia survey. The longitudinal effect was captured using a fixed
effect multinomial logistic regression model, which predicted changes in the relationship between cancer burden
and work disability level controlling for socio-demographic, lifestyle and life conditions predictors.
Results: The prevalence of long-term disability among cancer survivors was 50%, with 18% of patients experiencing
extreme work disability. The magnitude of disability levels increased significantly with the level of health burden.
Cancer survivors who faced a severe health burden were at 5.32 times significantly higher risk of having work
disability compared with patients who had no health burden. Other potential predictors, such as older patients
(relative risk ratio, RRR = 1.82; 95% CI: 1.57, 5.87), those engaged in lower levels of physical activities (RRR = 1.91; 95%
CI: 1.07, 3.40), those who drink alcohol (RRR = 1.29; 95% CI: 1.15, 1.49), and poor socioeconomic status (RRR = 1.28;
95% CI: 1.16, 2.23) were all significantly associated with extreme work disability.
Conclusion: A substantial proportion of cancer survivors experienced work disability which was more pronounced
with the magnitude of the cancer health burden. The different dimensions of disability might be prevented by
introducing cancer survivor-specific evidence-based interventions, and incorporating comprehensive social support.
Recommendations to improve public health policy aimed at reducing population-level unhealthy lifestyle
behaviours include: using these findings to better outline the management of a sequelae course of treatment for
cancer survivors; and identifying those who should undergo more intensive physical rehabilitation aimed at
reducing their work disability level.
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Background
Worldwide, work participation of cancer survivors has
seen a surge of attention in the last two of decades [1].
A cancer diagnosis can be a devastating and, often,life-
threatening experience [2], which frequently results in
short- or long-term disability [3–6] due to both health
and economic burdens [7]. Cancer imposes a substantial
burden in terms of reducing the autonomy of individuals
to perform their general daily activities [1, 8]. Further-
more, a cancer diagnosis negatively affects employment
status in terms of job opportunities, work participation
and work ability due to the illness [1, 8]. The adverse
side-effects of treatment results in physical and psycho-
logical limitations that can be a barrier to work partici-
pation [9]. However, the burden of physical disability
levels varies by cancer stages and types [10]. Cancer sur-
vivors run a significantly high risk of unemployment and
early retirement, and they have less opportunity to be
re-employed [1]. A cohort study showed that 20% of
cancer survivors reported disabilities due to cancer over
a 5 year follow-up period [11]. An estimated 30% of can-
cer survivors reported work disabilities post-treatment
[12]. However, a prospective cohort study confirmed
that the employment opportunities of cancer survivors
were adversely impacted by their recovery and health
status [13]. Return to work participation may assist can-
cer survivors to recover faster, improve their quality of
life, help return them to their former ‘normal’ life,
increase their self-confidence, and may support them to
overcome the negative side-effects of treatment [14, 15].
Furthermore, improvement of work participation of can-
cer survivors contributes to societal benefit, by reducing
absenteeism, and reducing disability benefit payments
and productivity losses [16]. Notably, cancer survivors’
earnings are 10% lower compared to non-cancer survi-
vors [17]. Therefore, there is a greater need to provide
supportive services (e.g., related to rehabilitation) to both
help cancer survivors adapt to disability, and prevent
work disability in this patient population.
In Australia, the incidence of cancer in individuals re-
sults in different disability levels for cancer survivors [2].
The long-term effects of cancer treatment are a signifi-
cant cause of greater absenteeism, higher unemployment
and early retirement [18], and overall reduced participa-
tion in work [2–6]. Approximately 40% of Australian
cancer patients are of working age [19], with 46% being
unable to return to employment after a cancer diagnosis
[20], and 67% changing their employment status follow-
ing diagnosed [21]. This results in a reduction of $1.7
billion to Australian gross domestic product (GDP)
annually [20]. The impact of work disability constitute a
substantial burden for people who have not had an
occupation due to cancer, as well as to their families and
employers. Furthermore, cancer-related treatment
results in patients experiencing economic burden due to
high out-of-pocket expenses (e.g., medicines and
advanced treatments, including diagnostics), lost prod-
uctivity, loss/reduction of household income, and other
induced expenditure [22]. The majority of cancer
patients depend on family, relatives and friends for phys-
ical and economic support during their course of treat-
ment and in the last stages of the disease [23, 24].
Ultimately, cancer survivors are faced with a double bur-
den in terms of their health and economic situation.
Existing studies have focused on cancer survivors’
characteristics and work participation, including in the
United States [1, 10, 12, 16, 25–27], Canada [3, 13],
South Korea [8], the Netherlands [5, 6, 9], and Belgium
[4, 28]. A number of factors adversely influencing work
participation of patients with cancer has been
determined in different settings. These parameters are
associated with patients’ socio-demographic characteris-
tics (e.g., age, educational status and economic position)
[5, 6, 9, 27], disease-related factors (e.g., tumor site,
advanced tumor stage), advanced course of treatment
(e.g., chemotherapy) [3, 6, 7, 27], and work-related fac-
tors (e.g., physical work demands) [1, 9]. The presence
of comorbid conditions in cancer patients creates a
higher likelihood of work-related disability [3]. That is,
cancer survivors with poor health status were signifi-
cantly correlated with a higher level of work disability
[27]. A study conducted in the Netherlands found that
cancer survivors who had experienced hormone therapy,
metastatic disease, had limited physical strength, and
limited workability, were strongly and adversely associ-
ated with a higher risk of work disability [5, 6]. The poor
perceptions of cancer survivors, in terms of their health
and work ability [6], their unhealthy behaviours (e.g.,
alcohol consumption), and their clinical stage [29] were
also significant predictors in determining independent
effects of their work disability levels.
In Australia, studies have been conducted among cancer
patients exploring the psychological effects of current
treatment or level of disability [30], association with work-
related stress and cancer [31], and lost productivity due to
cancer [20]. However, very limited evidence exists of the
health burden in relation to work disability of cancer sur-
vivors in Australia. That is, potential factors associated
with work disability of cancer survivors are poorly ex-
plored. This may be partially accounted for by various
study designs, analytical rigour and follow-up periods. For
instance, many international studies have used a limited
number of predictors. The majority of the previous studies
have been cross-sectional in nature, in terms of clinical
and treatment perspectives. Thus, a comprehensive study
is important to examine the impact of the health burden
in relation to the magnitude of work disability as a long-
term sequela of patients with cancer. There has been a
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recent surge of attention in the field of cancer survivor-
ship, leading to efforts to identify and manage treatment-
related sequelae, enhance quality of life, and improve the
overall functioning of people who are receiving long-term
follow-up care after cancer treatment.
Using longitudinal data from nationally representative
Australian samples, these findings will help to improve
the understanding of potential employment opportun-
ities after a cancer diagnosis. In addition, these findings
may be considered from different perspectives in cancer
policy discussions: the cancer survivor (e.g., health sta-
tus, work disability level, return to employment); the
caregiver and the family (e.g., the health burden, reduc-
tion of socio-economic position, risk of poverty); the
employer and co-workers (e.g., employment conditions,
workload); the health care provider (e.g., supportive care
needs, effective programs and interventions); and the
community or society (e.g., economic and policy
changes).
The present study aims to examine the health burden
impact on the magnitude of work disability of cancer
survivors after controlling several factors (e.g., socioeco-
nomic, lifestyle, healthcare utilisation, and geographical
location) over an extended period of 2003–2017. To
achieve the research aim, the following three research
questions (RQ) were posed:
RQ-1: What is the magnitude of work disability levels
among cancer patients in Australia?
RQ-2: What is the longitudinal association between
health burden and the magnitude of work disability
among cancer patients in Australia over 2003–2017?
RQ-3: What are the potential predictors associated
with the magnitude of work disability for cancer patients
in Australia over this extended period?
Methods
Setting and data source
The study was conducted in the context of Australia.
The Household, Income and Labour Dynamics in
Australia (HILDA) study is a nationally representative
household-based panel study. Data were collected
from Australia residents aged 15 or over through
face-to-face interviews and questionnaires, followed by
re-interviews with the people in subsequent years.
The details of the methods of data collection, includ-
ing the sampling technique, have been reported else-
where [32]. The overall goal of HILDA study is to
collect data on the lives of Australian residents in
terms of wealth, retirement, fertility, health, education,
skills and abilities. Households and individuals are
interviewed every year, allowing researchers to see
how participants’lives change over time. Household
longitudinal data, known as panel data, provides a
more complete picture than cross-sectional data as it
documents the life course each person takes. In many
cases, panel data allows causal inferences that are
more credible than those elicitedfrom other types of
data. In particular, statistical methods known as
‘fixed-effects’ regression models can be employed to
examine the effects of various factors on life out-
comes such as long-term health conditions, earnings,
unemployment, income and life satisfaction. These
models can control for the effects of stable character-
istics of individuals that are typically not observed,
such as innate ability, motivation and optimism, that
confound estimates of causal effects in cross-sectional
settings.
Study participants
The study was a sub-study with participants selected
based on inclusion criteria of the HILDAsurvey [32],
namely: 1) population aged 15 years or more (as per
HILDA study participants), ii) diagnosed cancer patients,
iii) longitudinal household members, and iv) willing to
participate in HILDA study. The study participants were
patients with cancer and data were derived from HILDA
waves 3, 7, 9, 13 and 17, all of which had a health focus
and asked specific questions related to cancer. Other
survey waves were excluded from this study due to the
paucity of cancer related information. A total of 2571
patients with diagnosed cancer were potential study par-
ticipants (Fig. 1) from the five waves (505 patients from
wave-3 in 2003, 557 patients from wave-7 in 2007, 416
patients from wave-9 in 2009, 517 patients from wave-
13 in 2013 and 576 patients from wave-17 in 2017).
Study design
The present study design was a mixed-longitudinal
quantitative design in patients with cancer. Individ-
uals who experienced a cancer diagnosis were exam-
ined with a focus on the magnitude of the cancer
burden associated with their long-term-disability. To
examine the mixed-longitudinal effects, this study
hypothesised that several factors related to individ-
uals’ socio-demographic characteristics, social factors,
and disease-related symptomatic factors might influ-
ence outcome factors like disability. The combin-
ation of factors was expected to predict the patients’
long-term disability or adverse occurrence.
Study variables
Outcome variable
Disability status and severity of disability were consid-
ered outcome measures. Work disability was measured
by asking participants if they had any long-term health
condition, impairment or disability that limited the kind
or amount of work they could do. The magnitude of dis-
ability level was measured based on patients’ responses
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as “Could you pick a number between 0 and 10 to indi-
cate how much your condition [s] limit [s] the amount
of work you can do?” The severity of disability score was
ranged from 0 to 10, with 10 indicating ‘able to do any
work’ and 0 indicating ‘not at all’. The severity of disabil-
ity level was defined as follows: (i) ‘no disability’ if dis-
ability score was equal to zero, (ii) ‘moderate disability’
for disability scores of 1 to 6, and (iii) ‘severe disability’
for disability scores of 7 to 10. The levels of disability
were considered dependent variables in the analytical
model.
Explanatory variables
This study considered several demographic, socio-
economic and health and lifestyle-related variables as
predictors of long-term disability. The demographic
variables included participant’s gender (male or fe-
male); age (< 25 years, 25–45 years, 46–65 years, or >
65 years), educational background (up to year 11,
year 12, trade/certificate/diploma, or tertiary educa-
tion), employment status (employed or unemployed),
marital status (single, married, other including sepa-
rated, divorced or widowed), and household size (< 3
members, 3 to 4 members, 5 or more members).
Ethnic status was defined as Aboriginal or non-
Aboriginal. Lifestyle factors include physical activity
status (low, moderate, or high). Life condition-
related variables such as satisfaction with household
members, overall employment situation, financial
situation and social supports were also considered as
potential predictors. The level of satisfaction-related
variables ranged from 0 (totally dissatisfied) to 10
(totally satisfied). Private insurance coverage of pa-
tients was dichotomous (insured or uninsured).
Medication status was defined as ‘with medication’
or ‘without medication’.
To measure the impact upon quality of life the short
form (SF)-36 was used. Health burden levels were
defined as follows: (1) high burden if SF-36 score was
less than 50, (2) moderate burden if SF-36 score was
greater than or equal to 50 but less than 90, (3) no bur-
den if SF-36 score was greater than or equal to 90 [33].
Remote locations were defined according to the accessi-
bility to services and the Remoteness Index of Australia
[34], and they were classified into five groups: major cit-
ies, inner regional, outer regional and remote or very
remote. The index of relative socio-economic disadvan-
tage (IRSD) was used to measure socio-economic status
(SES). T This is a geographical area-based estimate of
socio-economic status using a combination of income,
education level and occupation where communities are
ranked and categorised from economically disadvantaged
to wealthy.he cut-off values for each of the quintiles are
as follows: Q1 (IRSD ≤927.0), Q2 (927.0 > IRSD ≤965.8),
Q3 (965.8 > IRSD ≤1001.8), Q4 (1001.8 > IRSD ≤1056.0),
or Q5 (IRSD > 1056.0) [35].
Fig. 1 Distribution of study participants
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Statistical analysis
The overall cohort, and the subgroup that dropped out
over the course of study, were characterized using fre-
quency, means and proportions to summarise the partic-
ipants’ characteristics in terms of demographics,
unhealthy behaviours, life satisfaction, healthcare utilisa-
tion, remoteness and socioeconomic status. The associ-
ation between the level of disability or disability status
and the variables of greatest interest was analysed using
the chi-square test or one way analysis of variance
(ANOVA) where appropriate. During the analytical
exploration, the present study also considered the miss-
ing data mechanisms as suggested by Rubin et al. (1976)
and Little and Rubin (2002) [36, 37]. They classified the
missing data process into three mechanisms: missing
completely at random (MCAR), missing at random
(MAR), and non-ignorable missing (NIM). In the study
of work disability among cancer patients over time,
missing data are closed to MCAR if the probability of
attrition does not depend on the presence or severity of
work disability (i.e., no disability, moderate disability or
severe disability). A fixed-effects multinomial logistic
regression model was used for analysis under the
assumption of MCAR.
Both unadjusted and adjusted fixed-effect multinomial
logistic regression models were used to identify the
potential factors that had a significant role in the severity
of disability level. In the regression model, the
dependent variable (the severity of disability) was char-
acterised by a categorical variable with three different
levels (no disability, moderate disability or severe disabil-
ity). The model was tested for sensitivity by the forward
selection procedure (e.g., including and excluding spe-
cific variables) with the robust standard error. The pre-
dictor variables were included in the adjusted model
only if any label of the predictor was significant at ≤5%
risk level in the unadjusted regression model, which in
turn was used to adjust for the effects of other potential
confounders. Insignificant predictors were not included
in the adjusted model. For independent variables, the
category found to be least at risk of having an extreme
or moderate disability level in the analysis was consid-
ered as the reference for constructing relative risk ratio
(RRR), using fixed-effect multinomial logistic regression.
During the data analysis, the study also looked at inter-
action effects in the analytical exploration, the inter-
action effects of the magnitude of long-term work
disability in relation to RQ-3 by examining: age, employ-
ment status, life satisfactions, unhealthy behaviors and
socio-economic status. We did not include the inter-
action effects in the results section and tables because
the effects were insignificant in unadjusted model at a
borderline risk level (P = 0.125). All data analyses were
undertaken using the statistical software Stata/SE 13
(StataCorp, College Station, TX, USA). The statistical
significance was considered at a 5% risk level.
Results
Description of study participants
Data from 2571 cancer patients were included in the
analysis (Table 1). The percentage of male participants
(54%) was higher than the female (46%). Approximately
45% of patients were senior, aged (> 65 years), followed
by middle-aged (38%) (46 to 65 years). Approximately
47% had a middle or high school level education, with
15% of cancer patients having tertiary educationl qualifi-
cations. Approximately 45% of patients had limited
exposure to physical activity, and only 23% of patients
experienced high-level physical activities each week.
Two-thirds of participants drank alcohol frequently. The
majority of participants (90%) reported a moderate or
high health burden in terms of their quality of life. In
addition, 56% were insured, 72% received prescribed
medication, and 60% lived in major cities.
Distribution of disability status among cancer patients
(for RQ 1)
Table 2 shows participants’ characteristics, overall and
by disability status, across the selected variables. Half of
the male patients experienced a long-term disability.
The prevalence of disability increased significantly (P <
0.001) as patients aged (e.g., 17% for below 25 years, 27%
for 25–45 years, 42% for 46–65 years, 66% for more than
65 years old). Approximately 58% of patients who had
completed a middle or high school education level lived
with a disability, followed by 48% of tertiary educated
patients. The prevalence of disability was pronounced
amongst the unemployed (65%), those who were poorly
engaged in physical activities (61%) and those who were
uninsured (59%). Furthermore, the proportion of disabil-
ity was significantly aligned with the magnitude of can-
cer burden (e.g., 71% for severe burden, 45% for
moderate burden and 23% for no burden). Regarding
socio-economic status, the magnitude of work disability
was found to be highest in the lowest socio-economic
quintile. For example, patients who lived in the poorest
households (23%) were significantly exposed to long-
term disability (P < 0.001) compared with those in the
richest households (16%). However, an upward trend in
work disability levels was observed among the poorest
cancer survivors during 2003–2017 (Fig. 2).
Association between severity of disability and patient’s
characteristics (for RQ 2)
The age distribution of patients contributed significantly
(P < 0.001) to the magnitude of long-term disability
(Table 2). Educational background was significantly
associated with disability level (P < 0.001). Several patient
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Table 1 Characteristics of cancer patients by disability status
Variables n (%) / n
(mean)
Disability distribution among cancer survivors P-value
Any disability, n (%) No disability, n (%)
Sex
Male 1398 (54.38) 711 (50.86) 687 (49.14) 0.353
Female 1173 (45.62) 575 (49.02) 598 (50.98)
Age
< 25 years 63 (2.45) 11 (17.46) 52 (82.54) < 0.001
25–45 years 383 (14.90) 103 (26.89) 280 (73.11)
46–65 years 975 (37.92) 409 (41.95) 566 (58.05)
> 65 years 1150 (44.73) 763 (66.35) 387 (33.65)
Educational attainment
Year 12 or below 989 (38.47) 573 (57.94) 416 (42.06) < 0.001
Year 12 220 (8.56) 97 (44.09) 123 (55.91)
Trade/certificate/diploma 977 (38.00) 468 (47.90) 509 (52.10)
Tertiary 385 (14.97) 148 (38.44) 237 (61.56)
Employment status
Employed 974 (37.88) 247 (25.36) 727 (74.64) < 0.001
Unemployed 1597 (62.12) 1039 (65.06) 558 (34.94)
Physical activity status
Low 496 (45.38) 301 (60.69) 195 (39.31) < 0.001
Moderate 346 (31.66) 176 (50.87) 170 (49.13)
High 251 (22.96) 99 (39.44) 152 (60.56)
Alcohol consumption (= yes) 1903 (74.02) 887 (46.61) 1016 (53.39) < 0.001
Smoking exposure (= yes) 370 (14.39) 179 (48.38) 191 (51.62) 0.095
Health burden
No burden 257 (10.00) 59 (22.96) 198 (77.04) < 0.001
Moderate burden 1566 (60.91) 698 (44.57) 868 (55.43)
Severe burden 748 (29.09) 529 (70.72) 219 (29.28)
Private insurance coverage
Yes 613 (56.08) 292 (47.63) 321 (52.37) < 0.001
No 480 (43.92) 284 (59.17) 196 (40.83)
Healthcare utilisation
Yes 1093 (72.43) 682 (62.40) 411 (37.60) < 0.001
No 416 (27.57) 115 (27.64) 301 (72.36)
Life satisfaction with (mean scores)
Household members 2571 (8.20) 8.23 (1.85) 8.17 (1.83) 0.786
Employment 2571 (3.37) 2.29 (3.62) 4.45 (3.98) < 0.001
Financial situation 2571 (6.72) 6.54 (2.49) 6.89 (2.29) 0.005
Social supports 2571 (7.91) 7.79 (1.89) 8.03 (1.73) < 0.001
Remoteness
Major cities 1552 (60.37) 774 (49.87) 778 (50.13) < 0.001
Inner regional 660 (25.67) 336 (50.91) 324 (49.09)
Outer regional 314 (12.21) 158 (50.32) 156 (49.68)
Remote or very remote 45 (1.75) 18 (40.00) 27 (60.00)
Socioeconomic status
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characteristics including employment status (P < 0.001),
insurance coverage (P = 0.005), utilisation of prescribed
medication (P < 0.001), life satisfaction related-factors
(P < 0.05), alcohol consumption (P < 0.001), geographical
location (P < 0.001) and socio-economic status (P <
0.001) were significant predictors of disability level. Fur-
thermore, the level of physical activity (P < 0.001) and
the health burden related to cancer (P < 0.001) were
dominant variables for the severity of the disability.
Factors influencing disability among patients with cancer
(for RQ 3)
Table 3 shows the results of the fixed effect multinomial
logistic regression analysis. In the final model, age, edu-
cational achievement, physical activities, health burden
associated with cancer, utilisation of prescribed medica-
tion, patients living in a regional location, and those in
the poorest households were significant predictors of a
higher risk of long-term disability. An aged patient (> 65
years old) was at 1.82 times higher risk of having an
extreme disability (RRR = 1.82; 95% CI: 1.57, 5.87) com-
pared with a younger patient (< 25 years), while being
1.40 times more likely to have a moderate level of dis-
ability (RRR = 1.40; 95% CI: 1.09, 4.00). Patients who
were unemployed had a significantly higher risk of being
affected by severe disability (RRR = 2.01; 95% CI: 1.15,
3.50) or a moderate level of disability (RRR = 1.55; 95%
CI: 1.01, 2.39) compared with their employed counter-
parts. Similarly, patients who performed a lower level of
physical activities were 1.91 times more likely to have an
extreme disability (RRR = 1.91; 95% CI: 1.07, 3.40) com-
pared with patients engage in high-level physical activ-
ities. Patients who had an extreme health burden
associated with cancer were at approximately five times
significantly higher risk of experiencing a severe or mod-
erate disability level compared with patients who
reported excellent health status. Unhealthy behavioural
factors like alcohol consumption (RRR = 1.29; 95% CI:
1.15, 1.49) were associated with work disability com-
pared with patients who had not consumed alcohol. The
risks of having an extreme disability (RRR = 1.28 times)
or moderate disability level (RRR = 1.36 times) of cancer
patients who lived in the poorest households were more
pronounced compared with their richer counterparts.
Discussion
Cancer is significantly correlated with workdays lost and
high levels of work-related disability [29, 38–40]. The
main objectives of this study were to investigate the
magnitude of work disability due to a cancer diagnosis
and measure the longitudinal association between health
burden and disability, and the potential predictors of
work disability of cancer patients. The study results
show that 50% of cancer patients experienced a long-
term disability, whereas approximately 18% of patients
had reached an extreme level of work disability. Further-
more, the prevalence of disability was pronounced in
relation to the level of the cancer burden (e.g., 71% for
severe burden, 45% for moderate burden, and 23% for
no burden), aged patients (66%), and unemployed
patients (65%), those engaged in limited physical activ-
ities (61%), the uninsured (59%), and the poorest socio-
economic group (23%). Potential predictors, which
included factors such as age, those who exercise less or
not at all, those who have an extreme health burden,
and engage in unhealthy behaviours (e.g., alcohol con-
sumption), were significantly associated with a higher
risk of having an extreme disability.
The results showed that a higher risk of a severe or
moderate disability level was pronounced among cancer
patients who faced an extreme health burden, compared
with patients who reported an excellent health status. A
previous study found that poor health status of cancer
patients resulted in greater functional disability (e.g.,
specific task difficulties) [41, 42]. However, the preva-
lence of long-term disability was more pronounced in
combination with a cancer diagnosis [5, 6, 12, 27, 29].
Advanced cancer treatments can damage healthy cells or
organs [43]. For example, radiation and chemotherapy
may impose short and long-term health problems and
impact on the spinal cord, nerves and brain, which then
may significantly contribute to long-term adverse out-
comes like work-related disability. In the context of
Australia, a significant proportion (46%) of cancer
Table 1 Characteristics of cancer patients by disability status (Continued)
Variables n (%) / n
(mean)
Disability distribution among cancer survivors P-value
Any disability, n (%) No disability, n (%)
Q1 (lowest 20%) (ref) 516 (20.07) 293 (22.78) 223 (17.35) < 0.001
Q2 595 (23.14) 322 (25.04) 273 (21.25)
Q3 463 (18.01) 225 (17.50) 238 (18.52)
Q4 534 (20.77) 238 (18.51) 296 (23.04)
Q5 (highest 20%) 463 (18.01) 208 (16.17) 255 (19.84)
Overall 2571 (100.00) 1286 (50.02) 1285 (49.98)
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Table 2 Association of severity of disability and characteristics of cancer patients
Variables Severity of disability
No disability Moderate disability Severe disability P-value
n % (95% CI) n % (95% CI) n % (95% CI)
Sex
Male 816 58.37 (55.76, 60.93) 335 23.96 (21.80, 26.27) 247 17.67 (15.76, 19.76) 0.728
Female 672 57.29 (54.43, 60.10) 297 25.32 (22.91, 27.89) 204 17.39 (15.33, 19.67)
Age
< 25 years 46 73.02 (60.69, 82.58) 9 14.29 (7.56, 25.35) 8 12.70 (6.44, 23.51) < 0.001
25–45 years 285 74.41 (69.80, 78.54) 61 16.00 (12.59, 19.95) 37 9.66 (7.08, 13.06)
46–65 years 606 62.15 (59.06, 65.15) 214 21.95 (19.46, 24.66) 155 15.90 (13.73, 18.33)
> 65 years 551 47.91 (45.03, 50.81) 348 30.26 (27.67, 32.98) 251 21.83 (19.53, 24.31)
Educational attainment
Year 12 or below 489 49.44 (46.33, 52.56) 284 28.72 (25.98, 31.62) 216 21.84 (19.37, 24.53) < 0.001
Year 12 147 66.82 (60.31, 72.74) 36 16.36 (12.03, 21.87) 37 16.82 (12.42, 22.37)
Trade/certificate/diploma 588 60.18 (57.08, 63.21) 234 23.95 (21.38, 26.73) 155 15.86 (13.70, 18.29)
Tertiary 264 68.57 (63.75, 73.02) 78 20.26 (16.53, 24.58) 43 11.17 (8.38, 14.73)
Employment status
Employed 740 75.98 (73.19, 78.56) 158 16.22 (14.04, 18.67) 76 7.80 (6.27, 9.66) < 0.001
Unemployed 748 46.84 (44.40, 49.29) 474 29.68 (27.49, 31.97) 375 23.48 (21.47, 25.63)
Physical activity status
Low 233 46.98 (42.61, 51.39) 126 25.40 (21.76, 29.43) 137 27.62 (23.86, 31.73) < 0.001
Moderate 197 56.94 (51.65, 62.07) 101 29.19 (24.63, 34.21) 48 13.87 (10.61, 17.94)
High 176 70.12 (64.15, 75.47) 55 21.91 (17.21, 27.47) 20 7.97 (5.19, 12.04)
Alcohol consumption (= yes) 1175 61.74 (59.54, 63.90) 448 23.54 (21.69, 25.50) 280 14.71 (13.19, 16.38) < 0.001
Smoking exposure (= yes) 224 60.54 (55.46, 65.41) 82 22.16 (18.21, 26.69) 64 17.30 (13.77, 21.50) 0.455
Health burden
No burden 248 96.50 (93.40, 98.17) 7 2.72 (1.30, 5.61) 2 0.78 (0.19, 3.07) < 0.001
Moderate burden 1018 65.01 (62.61, 67.33) 403 25.73 (23.63, 27.96) 145 9.26 (7.92, 10.80)
Severe burden 222 29.68 (26.51, 33.06) 222 29.68 (26.51, 33.06) 304 40.64 (37.17, 44.21)
Private insurance coverage (= yes) 362 59.05 (55.10, 62.89) 155 25.29 (22.00, 28.89) 96 15.66 (12.99, 18.76) 0.005
Healthcare utilisation (= yes) 495 45.29 (42.35, 48.26) 340 31.00 (28.43, 33.92) 258 23.60 (21.18, 26.22) < 0.001
Life satisfaction with (mean scores)
Household members 1488 8.18 (8.09, 8.27) 632 8.24 (8.10, 8.38) 451 8.20 (8.01, 8.39) 0.034
Employment 1488 4.30 (4.10, 4.51) 632 2.48 (2.20, 2.77) 451 1.53 (1.25, 1.82) < 0.001
Financial situation 1488 6.94 (6.83, 7.06) 632 6.59 (6.40, 6.78) 451 6.15 (5.91, 6.39) < 0.001
Social supports 1488 8.01 (7.93, 8.09) 632 7.92 (7.78, 8.06) 451 7.61 (7.42, 7.80) < 0.001
Remoteness
Major cities 945 60.89 (58.43, 63.29) 347 22.36 (20.35, 24.50) 260 16.75 (14.97, 18.7) < 0.001
Inner regional 344 52.12 (48.30, 55.92) 194 29.39 (26.04, 32.99) 122 18.00 (15.70, 21.64)
Outer regional 169 53.82 (48.27, 59.28) 80 25.00 (20.95, 30.60) 65 20.70 (16.57, 25.55)
Remote or very remote 30 66.67 (51.65, 78.92) 11 24.44 (13.99, 39.16) 4 8.89 (3.34, 21.61)
Socioeconomic status
Q1 (lowest 20%) (ref) 258 50.00 (45.69, 54.31) 133 25.78 (22.18, 29.73) 125 24.22 (20.72, 28.12) < 0.001
Q2 312 52.44 (48.41, 56.43) 163 27.39 (23.96, 31.13) 120 20.17 (17.13, 23.59)
Q3 280 60.48 (55.94, 64.84) 120 25.92 (22.12, 30.11) 63 13.61 (10.77, 17.05)
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patients are unable to return to employment after their
diagnosis [20].
Furthermore, work disability leads to a substantial eco-
nomic burden on society, individuals and their families,
resulting in a reduction of $1.7 billion annually to GDP
in Australia [20] and an approximately 5% GDP reduc-
tion in the Organisation for Economic Co-operation and
Development (OECD) countries [44]. Therefore, cancer
survivors may require psycho-social healthcare services
and other therapeutic modalities, such as physical and
occupational therapy, to assist in their return to a pro-
ductive work life. Cancer patients with physically
demanding jobs may require assistance during treat-
ment, and possibly physical rehabilitation following
treatment, in order to minimize morbidity. However,
developing new and improved treatments with fewer
side effects is another potentially important strategy to
reduce cancer-related disability.
The results indicate that elderly cancer patients (older
than 65 years) were at a significantly higher risk of having
an extreme disability compared with younger patients (<
25 years). This finding is consistent with a previous study,
which revealed that elderly cancer patients reported signifi-
cantly more functional disabilities [45], required more
assistance with daily living activities [46], and had deficits in
performing work-related activities in terms of their physical
ability [41, 47]. Thus, several factors might influence the
reduction in their physical functioning. For example, a
course of advanced cancer treatment is associated with
considerable physical and psychological side effects in eld-
erly cancer patients (e.g., weight change, muscle loss, fatigue
and physical weakness) [48], and having multiple comor-
bidities [3, 27, 29] will presumably contribute to reduced
daily activities. Moreover, an elderly cancer patient may
have a limited acceptance of advanced treatment and health
outcomes that may then contribute to a greater burden of
health [48]. This result indicates that rehabilitation-related
interventions (e.g., occupational and physical therapies) are
essential to prevent ongoing work disability of cancer
patients [49], and is an emerging cancer research area, par-
ticularly focused on the elderly [50].
The study results found that low level or no physical
activities in cancer patients was strongly associated with
an extreme level of work-related disability compared
Table 2 Association of severity of disability and characteristics of cancer patients (Continued)
Variables Severity of disability
No disability Moderate disability Severe disability P-value
Q4 329 61.61 (57.41, 65.65) 119 22.28 (18.95, 26.02) 86 16.10 (13.22, 19.48)
Q5 (highest 20%) 309 66.74 (62.31, 70.89) 97 20.95 (17.48, 24.90) 57 12.31 (9.61, 15.63)
Overall 1488 57.88 (55.96, 59.77) 632 24.58 (22.95, 26.29) 451 17.54 (16.12, 19.06)
P-value was derived using chi-square test or one way analysis of variance (ANOVA) where appropriate
Fig. 2 Unequal distribution of health burden and upper extremity work disability across socioeconomic status
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Table 3 Factors influencing severity of disability of cancer patients
Variables Moderate disability vs No disability Severe disability vs No disability
Un-adjusted model Adjusted model Un-adjusted model Adjusted model
RRR (95% CI) RRR (95% CI) RRR (95% CI) RRR (95% CI)
Health burden
No burden (= ref) 1.00 1.00 1.00 1.00
Moderate burden 7.88*** (4.26, 10.04) 4.03*** (3.56, 9.99) 5.66*** (4.35, 7.79) 5.92** (1.38, 25.40)
Severe burden 7.27*** (6.28, 18.4) 5.43*** (3.34, 7.81) 6.80*** (4.78, 9.09) 5.32*** (2.75, 11.60)
Female (ref = male) 1.08 (0.89, 1.30) 1.00 (0.81, 1.24)
Age
< 25 years (= ref) 1.00 1.00 1.00 1.00
25–45 years 1.09 (0.51, 2.35) 1.12 (0.37, 3.37) 0.75 (0.33, 1.70) 0.85 (0.24, 2.97)
46–65 years 1.80 (0.87, 3.75) 1.31 (0.47, 3.66) 1.47 (0.68, 3.18) 1.39 (0.45, 4.34)
> 65 years 3.23*** (1.56, 6.68) 1.40** (1.09, 4.00) 2.62*** (1.22, 5.63) 1.82*** (1.57, 5.87)
Educational achievement
Year 11 or below (= ref) 1.00 1.00 1.00 1.00
Year 12 0.42*** (0.28, 0.62) 1.36 (0.82, 2.24) 0.57*** (0.38, 0.85) 0.77 (0.43, 1.39)
Trade/certificate/diploma 0.69*** (0.56, 0.85) 1.10 (0.51, 2.36) 0.60*** (0.47, 0.76) 1.54 (0.68, 3.47)
Tertiary or university 0.51*** (0.38, 0.68) 1.00 (0.62, 1.61) 0.37*** (0.26, 0.53) 0.77 (0.43, 1.36)
Unemployed (ref = employed) 2.97*** (3.65, 0.62) 1.55** (1.01, 2.39) 4.88*** (6.37, 0.85) 2.01*** (1.15, 3.50)
Marital status
Single (= ref) 1.00 1.00 1.00 1.00
Married 1.68*** (1.22, 2.32) 1.41 (0.79, 2.54) 1.33 (0.94, 1.88) 0.69 (0.37, 1.31)
Others 2.25*** (1.60, 3.16) 1.44 (0.79, 2.62) 1.86*** (1.29, 2.68) 0.89 (0.47, 1.69)
Physical activity status
Low 1.73*** (1.19, 2.51) 0.98 (0.64, 1.50) 5.17*** (3.11, 8.60) 1.91** (1.07, 3.40)
Moderate 1.64*** (1.11, 2.41) 1.30 (0.85, 2.00) 2.14*** (1.22, 3.75) 1.43 (0.77, 2.65)
High (= ref) 1.00 1.00 1.00 1.00
Alcohol consumption (ref = no) 1.54*** (1.25, 1.91) 0.94 (0.65, 1.35) 2.29*** (1.83, 2.88) 1.29*** (1.15, 1.49)
Smoking exposure (ref = no) 1.19 (0.91, 1.56) 1.07 (0.79, 1.45)
Private insurance coverage (ref = yes) 1.22 (0.91, 1.62) 0.88 (0.62, 1.24) 1.68*** (1.22, 2.32) 1.02 (0.68, 1.53)
Healthcare utilisation (ref = yes) 4.62*** (3.34, 6.39) 0.29*** (0.19, 0.44) 8.13*** (5.15, 12.83) 0.34*** (0.20, 0.60)
Life satisfaction with
Household members 1.02 (0.97, 1.07) 1.00 (0.90, 1.10) 1.01 (0.95, 1.07) 1.01 (0.90, 1.13)
Employment 0.89*** (0.87, 0.91) 0.99 (0.95, 1.04) 0.81*** (0.79, 0.84) 0.96 (0.91, 1.02)
Financial situation 0.94*** (0.90, 0.98) 0.95 (0.88, 1.03) 0.88*** (0.84, 0.91) 0.94 (0.86, 1.02)
Social supports 0.97 (0.92, 1.02) 1.00 (0.90, 1.10) 0.89*** (0.84, 0.94) 0.98 (0.88, 1.10)
Remoteness
Major cities (= ref) 1.00 1.00 1.00 1.00
Inner regional 1.54*** (1.24, 1.90) 1.75*** (1.21, 2.52) 1.29* (1.01, 1.65) 1.60** (1.04, 2.48)
Outer regional 1.29 (0.96, 1.73) 0.95 (0.55, 1.63) 1.40* (1.02, 1.92) 1.27 (0.70, 2.31)
Remote or very remote 1.00 (0.50, 2.01) 0.80 (0.26, 2.43) 0.48 (0.17, 1.39) 0.22 (0.03, 1.81)
Socioeconomic status
Q1 (lowest 20%) 1.64*** (1.21, 2.24) 1.36** (1.09, 2.33) 2.63*** (1.84, 3.74) 1.28*** (1.16, 2.23)
Q2 1.66*** (1.24, 2.24) 1.44 (0.87, 2.39) 2.09*** (1.47, 2.97) 1.25 (0.68, 2.32)
Q3 1.37* (1.00, 1.87) 1.49 (0.87, 2.54) 1.22 (0.82, 1.81) 1.09 (0.56, 2.14)
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with patients engaged in high-level physical activity. This
finding is consistent with other research [38, 51–54],
whereby authors found that limited physical activity
levels were significantly associated with a higher risk of
work disability among cancer patients. Further, a num-
ber of previous studies have proven that physical activity
plays an effective role in ensuring improved health status
[55], reducing the risk of developing future cancers [54],
and also expressively contributing to lower mortality risk
[56], which ultimately produces significant health bene-
fits and reduces medical expenditures and treatment
outcome disparities [55]. In terms of cancer risk, high
levels of physical activities (compared with low levels)
played a significant role in prevention of several cancers
(e.g., 42% for gastrointestinal cancer, 23% for renal can-
cer, and 20% for myeloid leukemia) [57]. This included
averting genetic damage, improving the immune system,
reducing chronic infections, and controlling cancer cells
[57]. Several hypotheses and mechanisms have been sug-
gested regarding the anti-cancer effects of physical activ-
ities. The American Cancer Society guidelines for cancer
survivors [58] recommend daily physical activities, in-
cluding a continuation of normal daily life activities im-
mediately after diagnosis, which help to significantly
reduce physical stamina and muscle strength erosion as
well as anxiety levels, thereby resulting in the prevention
of long-term adverse health outcomes (e.g., work-related
disability) [59].
This study results found an increased risk of work dis-
ability among cancer patients who consumed alcohol
compared with patients who did not. In this study, alco-
hol consumption had a robust effect on patient out-
comes. Formal drinkers represented two-thirds (≈ 75%)
of the cohort and had a 46% greater risk of disability.
The last Global Burden of Disease study, conducted in
2016, found a similar result, namely that alcohol con-
sumption was a dominating determinant for higher risk
of having a disability [60]. The World Health Organisa-
tion (WHO) has suggested that harmful alcohol con-
sumption causes a high burden of disease, including
cancer [61], which is often underappreciated [60]. This
finding has further implications for the reform of public
health policy, and decreasing population-level alcohol
consumption should be recommended.
The risks of having an extreme disability level amongst
cancer patients who lived in the poorest households
were more pronounced compared with their richer
counterparts. Recent studies have confirmed this result
with disadvantaged socio-economic status of cancer sur-
vivors being negatively associated with long-term health
effects or work-related disability [62, 63]. Some studies
have also provided evidence that the magnitude of the
cancer burden is negatively associated with socio-
economic status [16, 31–34]. Furthermore, adverse
health outcomes (e.g., worse health status, long and
short-term disability and shorter life expectancy) were
disproportionately found in poorer people as opposed to
those with higher socio-economic status [13, 16, 31, 33,
64–71]. Contribtuing factors to the high rates of long
term health impacts among the poorest groups includes
higher tobacco rates [16, 27], economic burden [35, 36],
increased mental illness [72], lack of health education
and awareness [73], and less access to competent and
effective health care services [73].
Low productivity, loss/reduction of household income,
and increased healthcare expenditure are pronounced
amongst the poorest cancer patients. Growing socio-
economic inequalities of cancer outcomes need the
attention of governments, health systems and decision
makers. For example, Cancer Australia has an optimal
care pathway project, which has already addressed sev-
eral cancer types. Such initiatives might help to reduce
socio-economic inequalities, which are related to pov-
erty, gender, education, and health, and should promote
universal access to health care which can further
enhance both socio-economic and human development.
The ability to continue in the labour force, and allow-
ing an individual the choice to do so, signifies a key
aspect of the health status often threatened by disease.
Long-term disability threatens the economic well-being
of survivors and their families. Additionally, the health
status of cancer patients who are restricted in their cap-
acity to work may be affected by the loss of identity, life
satisfaction, and social relationships that work often pro-
vides. Cancer survivorship, work disability and employ-
ment may be considered from different perspectives: the
cancer survivor (e.g., health status, work disability level
and return to employment), the caregiver and the family
Table 3 Factors influencing severity of disability of cancer patients (Continued)
Variables Moderate disability vs No disability Severe disability vs No disability
Un-adjusted model Adjusted model Un-adjusted model Adjusted model
RRR (95% CI) RRR (95% CI) RRR (95% CI) RRR (95% CI)
Q4 1.15 (0.85, 1.57) 1.21 (0.72, 2.01) 1.42 (0.98, 2.05) 1.36 (0.73, 2.52)
Q5 (highest 20%) (= ref) 1.00 1.00 1.00 1.00
RRR Relative risk ratio, CI Confidence interval, ref. Reference group
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(e.g., the health burden, reduction of socioeconomic pos-
ition and risk for poverty), the employer and co-workers
(e.g., employment conditions and workload), the health
care provider (e.g., supportive care needs, effective pro-
grams and interventions), and the community or society
(e.g., economic and policy changes).
This study includes some caveats. Study participants
were accessed from the HILDA survey, which covers
health, economic, employment, income and health char-
acteristics of household members aged 15 years and
older. Children who suffered from cancer were excluded
from this study. Examining the long-term work disability
is widely perceived to have substantial potential as an
endpoint in health outcomes research; however, results
are partially dependent upon study methods and out-
come variables of interest. The participants of the
present study were derived from the protocol “HILDA
study” [32], wherein long-terms health conditions of
cancer patients might change for independent study
designs as well as application of survey instruments.
This study findings established a relationship between
overall cancer burden and work-related disability among
cancer survivors, which might vary in terms of cancer
stages and types of cancer. The authors were not able to
estimate the cancer-specific health burden nor the work
disability of cancer survivors due to the paucity of rele-
vant data. Further, the study findings were based on self-
reported responses that might have been impacted by re-
spondents’ prejudice (e.g., silence and over-response),
and by problems in understanding and interpreting the
survey questions.
Despite these limitations, this study has noteworthy
strengths including the use of a prospective design of
long term follow-ups, and the application of well-
validated and reliable longitudinal wave measures of the
impacts of cancer diagnosis on the health burden and
work disability of individuals over the 2003–2017 period.
The study population was ethnically, geographically, and
socio-economically diverse. Furthermore, this study
included several potential confounding analytical factors
that were not present in previous studies. For this study,
data were gathered from five-waves of the HILDA survey
of cancer survivors. The length of the survey period may
have introduced uncontrolled bias, as changes in health
status are not instantaneous and might emerge only after
time, which was not captured in this study. Due to fund-
ing restrictions, the authors were unable to consider
cancer patients who registered for cancer surveillance as
well as received health care from health facilities (e.g.,
private clinics, community clinics, secondary or tertiary
hospitals). Due to the paucity of cancer-related data in
HILDA study, the authors were unable to perform
cancer-specific analysis and period of treatment analysis.
Future research is required using a similar study design,
perspective and analytical methods in terms of cancer-
specific exploration.
Conclusions
This study has identified a high rate of work-related dis-
ability that leads to a substantial decrease in a cancer
survivor’s socio-economic position. Several demographic,
social, lifestyle and health burden variables were associ-
ated with the magnitude of disability. The findings have
further implications for improving public health policy,
and reducing population-level unhealthy lifestyle behav-
iours which should be recommended. The study results
could be used to better outline the management of a
sequelae course of treatment for those who should
undergo more intensive physical rehabilitation aimed at
reducing work disability levels. This may apply to cancer
survivors who choose or need to work after cancer diag-
nosis and treatment especially those still active in the
work force. This is important in light of the increasing
prevalence of cancer and fortunately, the growing num-
bers of patients surviving cancer in Australia, and the
likelihood of the development of impairments and activ-
ity limitations after cancer treatment. It is also signifi-
cant for health care providers, including physical and
occupational therapists and oncologists, who should be
aware of the unique problems that challenge this popu-
lation and who should advocate for prevention and
evidence-based interventions. Therefore, it is recom-
mended that effective and efficient cancer survivor-
specific evidence-based interventions be developed to
reduce the impacts of work disability by incorporating
comprehensive social supports which ultimately, have
the potential to affect the trajectory of the cancer burden
in a positive way.
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